Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis

ACCP Treatment Duration Guidelines³

June 2011

Well, do the treatment guidelines help us under these circumstances and the answer is they don’t really help us that much. Because for an idiopathic venous thrombotic event, the guidelines support the use of 3 months of anticoagulation. But they also support the use of prolonged secondary prophylaxis and both of these guidelines get a Grade 1A recommendation.

< Previous Slide

ACCP Treatment Duration Guidelines3

Next Slide >

 

Jump to section:

• Introduction
• Independent Risk Factors for Venous Thromboembolism¹
• Thrombophilia Testing
• ACCP Treatment Duration Guidelines²
• Aggressive Thrombophilia²
• Case
• Case
• Recurrence Rate
• ACCP Treatment Duration Guidelines³
• D-Dimer Levels and Risk of Recurrent Venous Thromboembolism⁴
• PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation⁵
• PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation⁵
• Idiopathic VTE
• Residual Vein Thrombosis (RVT) to Assess Optimal Management of DVT: DACUS Study⁶
• Residual Vein Thrombosis (RVT) to Determine Duration of Anticoagulation⁶
• Recurrent VTE by RVT at 3 Months: DACUS Study⁶
• Non-compressed vs. Compressed
• Idiopathic DVT: Take Home Point
• Case (revisited)
• Case (revisited)
• Mortality Risk
• Cumulative Recurrence of DVT vs PE After Incident DVT
• Cumulative Recurrence of DVT vs PE After Incident PE
• Independent Predictors of Death within 7 Days of Venous Thromboembolism Recurrence
• Idiopathic PE – Take Home Points
• References
• Clinical and Laboratory Update in Thrombosis and Anticoagulation
• Questions?